Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
South Med J ; 114(2): 86-91, 2021 02.
Artículo en Inglés | MEDLINE | ID: mdl-33537789

RESUMEN

OBJECTIVES: Diabetes mellitus (DM) increases the risk of cardiovascular disease and is associated with sudden death. Mental illness among individuals with DM may confound medical care. This study assessed the association of mental illness with DM and poorly controlled DM in sudden death victims. METHODS: We screened out-of-hospital deaths ages 18 to 64 years in Wake County, North Carolina from 2013 to 2015 to adjudicate sudden deaths. We abstracted demographics and clinical characteristics from health records. Mental illness included anxiety, schizophrenia, bipolar disorder, or depression. Poorly controlled DM was defined as a hemoglobin A1c >8 or taking ≥3 medications for glycemic control. Logistic regression assessed the association between DM and mental illness. RESULTS: Among victims with available records, 109 (29.4%) had DM. Of those, 62 (56.9%) had mental illness. Mental illness was present in 53.42% and 63.89% of victims with mild and poorly controlled DM, respectively. Mental illness was associated with DM (adjusted odds ratio 2.46, 95% confidence interval 1.57-3.91). Victims with poorly controlled DM were more likely to have mental illness (adjusted odds ratio 2.66, 95% confidence interval 1.14-6.18). CONCLUSIONS: DM is a common comorbid condition in sudden death victims. Among victims, mental illness is associated with the control of DM. Early management of comorbid mental illnesses may improve the care of patients with DM and reduce the incidence of sudden death.


Asunto(s)
Muerte Súbita/epidemiología , Diabetes Mellitus/epidemiología , Trastornos Mentales/epidemiología , Adolescente , Adulto , Comorbilidad , Muerte Súbita/etiología , Femenino , Hemoglobina Glucada/análisis , Humanos , Incidencia , Modelos Logísticos , Masculino , Persona de Mediana Edad , North Carolina/epidemiología , Oportunidad Relativa , Prevalencia , Adulto Joven
2.
Adv Exp Med Biol ; 961: 411-8, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23224899

RESUMEN

The Na(+)/H(+) exchangers (NHEs) are a family of membrane transporter proteins which catalyze the electroneutral exchange of one Na(+) for one H(+) and thus regulate intracellular pH (pH(i)) and cell volume. It is shown that Na(+)/H(+) exchanger isoform 1 (NHE-1), but not other isoforms, is the important mechanism in extruding H(+) and regulating pH(i) in the immune system. Immune cells, such as monocytes and neutrophils, generate reactive oxygen species (ROS) and cytokines in response to various stimuli and provide the first line of defense in the immune system. NHE-1 is activated during this respiratory burst and required to maintain an optimal pH(i) for the immune cells. In the central nervous system, NHE-1 is important for microglial (macrophage) activation and participates in the inflammatory response under pathological conditions including cerebral ischemia and traumatic brain injury. NHE-1 also affects Ca(2+) homeostasis in microglia and contributes to the increase of [Ca(2+)](i) by coupling to the Na(+)/Ca(2+) exchanger (NCX) stimulation, thus regulating immune cell function and participating in ischemic cell death. A better understanding of the function of NHE-1 in inflammatory responses will provide insight into its role in brain damage under disease conditions.


Asunto(s)
Proteínas de Transporte de Catión/inmunología , Activación de Macrófagos/inmunología , Macrófagos/inmunología , Especies Reactivas de Oxígeno/inmunología , Estallido Respiratorio/inmunología , Intercambiadores de Sodio-Hidrógeno/inmunología , Animales , Lesiones Encefálicas/genética , Lesiones Encefálicas/inmunología , Lesiones Encefálicas/metabolismo , Isquemia Encefálica/genética , Isquemia Encefálica/inmunología , Isquemia Encefálica/metabolismo , Proteínas de Transporte de Catión/genética , Proteínas de Transporte de Catión/metabolismo , Humanos , Concentración de Iones de Hidrógeno , Inflamación/genética , Inflamación/inmunología , Inflamación/metabolismo , Activación de Macrófagos/genética , Macrófagos/metabolismo , Microglía/inmunología , Microglía/metabolismo , Isoformas de Proteínas/genética , Isoformas de Proteínas/inmunología , Isoformas de Proteínas/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Estallido Respiratorio/genética , Intercambiador 1 de Sodio-Hidrógeno , Intercambiadores de Sodio-Hidrógeno/genética , Intercambiadores de Sodio-Hidrógeno/metabolismo
3.
Diabetes Technol Ther ; 22(6): 444-448, 2020 06.
Artículo en Inglés | MEDLINE | ID: mdl-32396395

RESUMEN

Introduction: During the coronavirus disease 2019 (COVID-19) outbreak, novel approaches to diabetes care have been employed. Care in both the inpatient and outpatient setting has transformed considerably. Driven by the need to reduce the use of personal protective equipment and exposure for patients and providers alike, we transitioned inpatient diabetes management services to largely "virtual" or remotely provided care at our hospital. Methods: Implementation of a diabetes co-management service under the direction of the University of North Carolina division of endocrinology was initiated in July 2019. In response to the COVID-19 pandemic, the diabetes service was largely transitioned to a virtual care model in March 2020. Automatic consults for COVID-19 patients were implemented. Glycemic outcomes from before and after transition to virtual care were evaluated. Results: Data over a 15-week period suggest that using virtual care for diabetes management in the hospital is feasible and can provide similar outcomes to traditional face-to-face care. Conclusion: Automatic consults for COVID-19 patients ensure that patients with serious illness receive specialized diabetes care. Transitioning to virtual care models does not limit the glycemic outcomes of inpatient diabetes care and should be employed to reduce patient and provider exposure in the setting of COVID-19. These findings may have implications for reducing nosocomial infection in less challenging times and might address shortage of health care providers, especially in the remote areas.


Asunto(s)
Infecciones por Coronavirus/prevención & control , Infección Hospitalaria/prevención & control , Diabetes Mellitus/terapia , Pandemias/prevención & control , Transferencia de Pacientes/métodos , Neumonía Viral/prevención & control , Telemedicina/métodos , Betacoronavirus , COVID-19 , Infecciones por Coronavirus/complicaciones , Infección Hospitalaria/virología , Diabetes Mellitus/virología , Estudios de Factibilidad , Femenino , Humanos , Masculino , Grupo de Atención al Paciente , Neumonía Viral/complicaciones , SARS-CoV-2
4.
J Clin Endocrinol Metab ; 104(10): 4473-4480, 2019 10 01.
Artículo en Inglés | MEDLINE | ID: mdl-31188435

RESUMEN

CONTEXT/OBJECTIVE: Increased PTH after successful parathyroid surgery represents a clinical conundrum. We aimed to determine the prevalence of persistently elevated PTH (PePTH) postsurgery, along with predisposing factors. DESIGN: and Setting: Patients ≥ age 18 with parathyroidectomy performed at University of North Carolina Hospitals for primary hyperparathyroidism (PHPT) over a 12-year period were identified from the Carolina Data Warehouse. Clinical and demographic characteristics were collected, transformed, and analyzed. RESULTS: Five hundred seventy patients met initial criteria for PHPT, and of those 407 had postoperative values. One hundred forty-four had laboratory results within 3 to 18 months post operatively. There was no clinical difference between those with and without long-term laboratory follow-up. Presurgery, patients had average calcium of 11 mg/dL and PTH 125.4 pg/mL. Ninety-seven percent of patients had normalized calcium after surgery, but 30% had PePTH, which can be predicted at 3 months. Patients with PePTH (persistent elevation of PTH) after surgery did not differ from those with normalized PTH in terms of sex, age, body mass index, or excised gland weight; presurgery 25-vitamin D was slightly lower, but not abnormal (26 ± 15 vs 36 ± 11). The presurgical PTH was significantly higher (P < 0.001) in those with PePTH (156.5 pg/mL compared with presurgical level of 102.5 in those whose PTH normalized). CONCLUSIONS: Nearly one-third of PHPT patients have elevated PTH levels postsurgery in a tertiary hospital setting. At presentation, patients with PePTH tend to have higher PTH relative to calcium levels. Whether PePTH after surgical treatment of PHPT has pathological consequences is unknown.


Asunto(s)
Calcio/sangre , Hiperparatiroidismo Primario/cirugía , Hormona Paratiroidea/sangre , Paratiroidectomía , Vitamina D/análogos & derivados , Adulto , Anciano , Femenino , Humanos , Hipercalcemia/etiología , Hiperparatiroidismo Primario/sangre , Hiperparatiroidismo Primario/complicaciones , Masculino , Persona de Mediana Edad , Tamaño de los Órganos , Glándulas Paratiroides/patología , Periodo Posoperatorio , Estudios Retrospectivos , Centros de Atención Terciaria , Insuficiencia del Tratamiento , Vitamina D/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA